S08965 Summary:

BILL NOS08965A
 
SAME ASSAME AS A06799-B
 
SPONSORRIVERA
 
COSPNSR
 
MLTSPNSR
 
Amd 207, Pub Health L
 
Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.
Go to top    

S08965 Actions:

BILL NOS08965A
 
04/03/2024REFERRED TO HEALTH
04/08/2024AMEND AND RECOMMIT TO HEALTH
04/08/2024PRINT NUMBER 8965A
04/17/20241ST REPORT CAL.838
04/18/20242ND REPORT CAL.
04/19/2024ADVANCED TO THIRD READING
Go to top

S08965 Committee Votes:

Go to top

S08965 Floor Votes:

There are no votes for this bill in this legislative session.
Go to top

S08965 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         8965--A
 
                    IN SENATE
 
                                      April 3, 2024
                                       ___________
 
        Introduced  by  Sen.  RIVERA -- read twice and ordered printed, and when
          printed to be committed  to  the  Committee  on  Health  --  committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee
 
        AN  ACT  to  amend  the public health law, in relation to establishing a
          drug-induced movement disorder screening education program

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Subdivision  1 of section 207 of the public health law is
     2  amended by adding a new paragraph (h) to read as follows:
     3    (h) The department shall develop  and  conduct  a  program  concerning
     4  drug-induced  movement  disorders. Such program shall include but not be
     5  limited to, (i) educational information on the importance  of  screening
     6  for  and  identifying  symptoms  of drug-induced movement disorders; and
     7  (ii) the development and  dissemination  of  educational  materials  for
     8  healthcare  providers  regarding  treatment  for  drug-induced  movement
     9  disorders, including for services provided via telehealth.  Such  educa-
    10  tional materials disseminated to healthcare providers shall be developed
    11  and  disseminated  in  coordination  with  relevant  healthcare provider
    12  groups and shall include best practices for the treatment and  screening
    13  of  movement  disorders informed by the American Psychiatric Association
    14  and other professional society practice guidelines.  Such program  shall
    15  also  include  education  and  outreach on the elimination of stigma for
    16  people living with drug-induced movement disorders related to the treat-
    17  ment of mental health conditions.
    18    § 2. This act shall take effect on the ninetieth day  after  it  shall
    19  have become a law. Effective immediately, the addition, amendment and/or
    20  repeal  of  any  rule  or regulation necessary for the implementation of
    21  this act on its effective date are authorized to be made  and  completed
    22  on or before such effective date.
 
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD10964-04-4
Go to top